Please enable JavaScript to continue using this application.

Compare $PDSB vs $SERA | Chartloom

Compare

$PDSB vs $SERA

PDS Biotechnology Corp · Sera Prognostics Inc

PDSB

PDS Biotechnology Corp

SERA

Sera Prognostics Inc

Compare $PDSB vs $SERA

Comparing PDS Biotechnology Corp and Sera Prognostics Inc

PDSBPDS Biotechnology Corp

SERASera Prognostics Inc

PDSBPDS Biotechnology Corp

Market cap

$77M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

65.6%

52W performance

38.0%

FCF yield

-21.7%

SERASera Prognostics Inc

Market cap

$80M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

89.94x

Rev growth (TTM)

-35.2%

YTD performance

-32.0%

52W performance

-35.2%

FCF yield

-35.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PDSB

SERA

Detailed metrics comparison

PDSB

PDS Biotechnology Corp

SERA

Sera Prognostics Inc

Market Cap

PDSB$77M

SERA$80M

Enterprise Value

PDSB$76M

SERA$75M

Price

PDSB$1.38

SERA$2.04

P/E Ratio

PDSBN/A

SERAN/A

P/S Ratio

PDSB0.00x

SERA1,141.23x

EV/Sales

PDSB0.00x

SERA1,078.41x

EV/EBITDA

PDSB0.00x

SERA0.00x

P/B Ratio

PDSB10.76x

SERA1.39x

P/FCF Ratio

PDSBN/A

SERAN/A

EV/FCF

PDSB-4.52x

SERA-2.68x

PEG Ratio

PDSBN/A

SERAN/A

Forward P/E (NTM)

PDSBN/A

SERAN/A

Forward P/S (NTM)

PDSBN/A

SERA89.94x

Revenue (TTM)

PDSB$0

SERA$70K

Revenue Growth (YoY)

PDSBN/A

SERA-35.2%

Forward Rev Growth

PDSB4816.2%

SERA791.9%

Gross Margin (TTM)

PDSB0.0%

SERA-150.0%

Operating Margin (TTM)

PDSB0.0%

SERA0.0%

EBITDA Margin (TTM)

PDSB0.0%

SERA-50200.0%

Net Margin (TTM)

PDSB0.0%

SERA-47475.7%

FCF Margin (TTM)

PDSBN/A

SERA-40262.9%

Net Income (TTM)

PDSB$-34M

SERA$-33M

FCF (TTM)

PDSB$-17M

SERA$-28M

EPS (TTM)

PDSB-$0.60

SERA-$0.66

ROE (TTM)

PDSB-34603.0%

SERA-4671.0%

ROA (TTM)

PDSB-13650.0%

SERA-3406.0%

ROIC (TTM)

PDSB-12371.0%

SERA-4671.0%

Cash

PDSB$6M

SERA$4M

Debt

PDSB$4M

SERA$0

Net Cash/Debt

PDSB$1M

SERA$4M

Current Ratio (TTM)

PDSB0.57x

SERA1.98x

Quick Ratio (TTM)

PDSB0.45x

SERA1.91x

Debt/Equity (TTM)

PDSB4.07x

SERA0.00x

Debt/Assets (TTM)

PDSB0.0%

SERA0.0%

Interest Coverage (TTM)

PDSBN/A

SERAN/A

Net Debt/EBITDA (TTM)

PDSB0.00x

SERA0.00x

Beta

PDSB1.30

SERA1.09

52W Performance

PDSB38.0%

SERA-35.2%

YTD Performance

PDSB65.6%

SERA-32.0%

% from 52W High

PDSB-11.0%

SERA-48.4%

% from 52W Low

PDSB607.0%

SERA30.8%

Asset Turnover (TTM)

PDSB0.00x

SERA0.00x

FCF Yield (TTM)

PDSB-21.7%

SERA-35.3%

Earnings Yield (TTM)

PDSB-43.6%

SERA-41.6%

Dividend Yield (TTM)

PDSBN/A

SERAN/A

Rule of 40

PDSB0.0

SERA-40,298.0

EV/GP/RG

PDSBN/A

SERAN/A

Ticker research

View PDSB research View SERA research

Metric	PDSB PDS Biotechnology Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$77M	$80M
Enterprise Value	$76M	$75M
Price	$1.38	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,141.23x
EV/Sales	0.00x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.76x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.52x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$0	$70K
Revenue Growth (YoY)	N/A	-35.2%
Forward Rev Growth	4816.2%	791.9%
Profitability
Gross Margin (TTM)	0.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-50200.0%
Net Margin (TTM)	0.0%	-47475.7%
FCF Margin (TTM)	N/A	-40262.9%
Net Income (TTM)	$-34M	$-33M
FCF (TTM)	$-17M	$-28M
EPS (TTM)	-$0.60	-$0.66
ROE (TTM)	-34603.0%	-4671.0%
ROA (TTM)	-13650.0%	-3406.0%
ROIC (TTM)	-12371.0%	-4671.0%
Financial Health
Cash	$6M	$4M
Debt	$4M	$0
Net Cash/Debt	$1M	$4M
Current Ratio (TTM)	0.57x	1.98x
Quick Ratio (TTM)	0.45x	1.91x
Debt/Equity (TTM)	4.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.30	1.09
52W Performance	38.0%	-35.2%
YTD Performance	65.6%	-32.0%
% from 52W High	-11.0%	-48.4%
% from 52W Low	607.0%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.7%	-35.3%
Earnings Yield (TTM)	-43.6%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View PDSB research	View SERA research

Valuation

P/S Ratio

PDSB

0.00x

SERA

1,141.23x

EV/FCF

PDSB

-4.52x

SERA

-2.68x

Growth & revenue

Revenue Growth TTM

SERA

-35.2%

Forward Revenue Growth

PDSB

4816.2%

SERA

791.9%

Profitability & performance

Gross Margin

PDSB

0.0%

SERA

-150.0%

ROE

SERA

-4671.0%

PDSB

-34603.0%

FCF Yield %

PDSB

-21.7%

SERA

-35.3%

52-Week Performance

PDSB

38.0%

SERA

-35.2%

Detailed metrics comparison

PDSB

PDS Biotechnology Corp

SERA

Sera Prognostics Inc

Market Cap

PDSB$77M

SERA$80M

Enterprise Value

PDSB$76M

SERA$75M

Price

PDSB$1.38

SERA$2.04

P/E Ratio

PDSBN/A

SERAN/A

P/S Ratio

PDSB0.00x

SERA1,141.23x

EV/Sales

PDSB0.00x

SERA1,078.41x

EV/EBITDA

PDSB0.00x

SERA0.00x

P/B Ratio

PDSB10.76x

SERA1.39x

P/FCF Ratio

PDSBN/A

SERAN/A

EV/FCF

PDSB-4.52x

SERA-2.68x

PEG Ratio

PDSBN/A

SERAN/A

Forward P/E (NTM)

PDSBN/A

SERAN/A

Forward P/S (NTM)

PDSBN/A

SERA89.94x

Revenue (TTM)

PDSB$0

SERA$70K

Revenue Growth (YoY)

PDSBN/A

SERA-35.2%

Forward Rev Growth

PDSB4816.2%

SERA791.9%

Gross Margin (TTM)

PDSB0.0%

SERA-150.0%

Operating Margin (TTM)

PDSB0.0%

SERA0.0%

EBITDA Margin (TTM)

PDSB0.0%

SERA-50200.0%

Net Margin (TTM)

PDSB0.0%

SERA-47475.7%

FCF Margin (TTM)

PDSBN/A

SERA-40262.9%

Net Income (TTM)

PDSB$-34M

SERA$-33M

FCF (TTM)

PDSB$-17M

SERA$-28M

EPS (TTM)

PDSB-$0.60

SERA-$0.66

ROE (TTM)

PDSB-34603.0%

SERA-4671.0%

ROA (TTM)

PDSB-13650.0%

SERA-3406.0%

ROIC (TTM)

PDSB-12371.0%

SERA-4671.0%

Cash

PDSB$6M

SERA$4M

Debt

PDSB$4M

SERA$0

Net Cash/Debt

PDSB$1M

SERA$4M

Current Ratio (TTM)

PDSB0.57x

SERA1.98x

Quick Ratio (TTM)

PDSB0.45x

SERA1.91x

Debt/Equity (TTM)

PDSB4.07x

SERA0.00x

Debt/Assets (TTM)

PDSB0.0%

SERA0.0%

Interest Coverage (TTM)

PDSBN/A

SERAN/A

Net Debt/EBITDA (TTM)

PDSB0.00x

SERA0.00x

Beta

PDSB1.30

SERA1.09

52W Performance

PDSB38.0%

SERA-35.2%

YTD Performance

PDSB65.6%

SERA-32.0%

% from 52W High

PDSB-11.0%

SERA-48.4%

% from 52W Low

PDSB607.0%

SERA30.8%

Asset Turnover (TTM)

PDSB0.00x

SERA0.00x

FCF Yield (TTM)

PDSB-21.7%

SERA-35.3%

Earnings Yield (TTM)

PDSB-43.6%

SERA-41.6%

Dividend Yield (TTM)

PDSBN/A

SERAN/A

Rule of 40

PDSB0.0

SERA-40,298.0

EV/GP/RG

PDSBN/A

SERAN/A

Ticker research

View PDSB research View SERA research

Metric	PDSB PDS Biotechnology Corp	SERA Sera Prognostics Inc
Market & Valuation
Market Cap	$77M	$80M
Enterprise Value	$76M	$75M
Price	$1.38	$2.04
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	1,141.23x
EV/Sales	0.00x	1,078.41x
EV/EBITDA	0.00x	0.00x
P/B Ratio	10.76x	1.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.52x	-2.68x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	89.94x
Revenue & Growth
Revenue (TTM)	$0	$70K
Revenue Growth (YoY)	N/A	-35.2%
Forward Rev Growth	4816.2%	791.9%
Profitability
Gross Margin (TTM)	0.0%	-150.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-50200.0%
Net Margin (TTM)	0.0%	-47475.7%
FCF Margin (TTM)	N/A	-40262.9%
Net Income (TTM)	$-34M	$-33M
FCF (TTM)	$-17M	$-28M
EPS (TTM)	-$0.60	-$0.66
ROE (TTM)	-34603.0%	-4671.0%
ROA (TTM)	-13650.0%	-3406.0%
ROIC (TTM)	-12371.0%	-4671.0%
Financial Health
Cash	$6M	$4M
Debt	$4M	$0
Net Cash/Debt	$1M	$4M
Current Ratio (TTM)	0.57x	1.98x
Quick Ratio (TTM)	0.45x	1.91x
Debt/Equity (TTM)	4.07x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.30	1.09
52W Performance	38.0%	-35.2%
YTD Performance	65.6%	-32.0%
% from 52W High	-11.0%	-48.4%
% from 52W Low	607.0%	30.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-21.7%	-35.3%
Earnings Yield (TTM)	-43.6%	-41.6%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-40,298.0
EV/GP/RG	N/A	N/A
Ticker research	View PDSB research	View SERA research